Streetbeat News

Equity Actions

CCCS

CCC Intelligent Solutions Holdings shares are trading lower after the company announced a proposed public offering of 50 million shares by selling shareholders.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:38 pm

CCCS

CCC Intelligent Solutions has announced a proposed offering of 50 million shares by selling shareholders.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:35 pm

OCN

Ocwen Financial Corporation has received shareholder approval to rebrand as Onity Group Inc. The new name and NYSE trading symbol 'ONIT' are expected to be effective on June 10, 2024. Additionally, PHH Mortgage will rebrand to Onity Mortgage in the fall of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:25 pm

BWMX

BeFra is transferring the listing and trading of its common stock from Nasdaq to NYSE, effective June 7, 2024. The stock will continue to trade under the ticker symbol 'BWMX'.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:19 pm

IKNA

Ikena Oncology has announced that it will discontinue the development of its drug candidate IK-930. The company is also evaluating strategic options for its overall development pipeline and the company itself.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:16 pm

NBIX

Neurocrine Biosciences announced that CEO Kevin Gorman will retire on October 11, 2024, and will be succeeded by Kyle Gano, Ph.D., the current Chief Business Development and Strategy Officer. Gano will also join the Board of Directors, while Gorman will continue to serve on the Board.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:16 pm

GYRE

Gyre Therapeutics is expected to be added to the Russell 2000 and Russell 3000 indexes. This inclusion is likely to increase the stock's visibility and attract more institutional investors.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:15 pm

FPI

Farmland Partners has appointed Susan Landi as the new Chief Financial Officer (CFO).

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:14 pm

CMPX

Compass Therapeutics has appointed Thomas Schuetz as President and CEO, effective May 28, 2024. Vered Bisker-Leib has stepped down but will remain as a Senior Consultant for the next 15 months.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:13 pm

ANIK

Anika Therapeutics has authorized a $40 million share repurchase program, indicating confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:09 pm